Your browser doesn't support javascript.
loading
PM2.5-mediated cardiovascular disease in aging: Cardiometabolic risks, molecular mechanisms and potential interventions.
Chanda, Francis; Lin, Kai-Xuan; Chaurembo, Abdallah Iddy; Huang, Jian-Yuan; Zhang, Hui-Juan; Deng, Wen-Hui; Xu, Yun-Jing; Li, Yuan; Fu, Li-Dan; Cui, Hao-Dong; Shu, Chi; Chen, Yang; Xing, Na; Lin, Han-Bin.
Afiliação
  • Chanda F; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; University of Chinese Academy of Sciences, Beijing, China.
  • Lin KX; Department of Cardiology, Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Traditional Chinese Medicine, Zhongshan, Guangdong, China; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Chaurembo AI; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; University of Chinese Academy of Sciences, Beijing, China.
  • Huang JY; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong, China.
  • Zhang HJ; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.
  • Deng WH; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong, China.
  • Xu YJ; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; University of Chinese Academy of Sciences, Beijing, China.
  • Li Y; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Fu LD; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.
  • Cui HD; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
  • Shu C; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; Food Science College, Shenyang Agricultural University, Shenyang, Liaoning, China.
  • Chen Y; University of Chinese Academy of Sciences, Beijing, China; Research Center for Atmospheric Environment, Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing, China.
  • Xing N; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China. Electronic address: xingna@zidd.ac.cn.
  • Lin HB; Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, Guangdong, China; State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; University of Chinese Academy of Sciences, Beijing, China. Electronic address: linhanbin@simm.
Sci Total Environ ; 954: 176255, 2024 Sep 12.
Article em En | MEDLINE | ID: mdl-39276993
ABSTRACT
Air pollution, particularly fine particulate matter (PM2.5) with <2.5 µm in diameter, is a major public health concern. Studies have consistently linked PM2.5 exposure to a heightened risk of cardiovascular diseases (CVDs) such as ischemic heart disease (IHD), heart failure (HF), and cardiac arrhythmias. Notably, individuals with pre-existing age-related cardiometabolic conditions appear more susceptible. However, the specific impact of PM2.5 on CVDs susceptibility in older adults remains unclear. Therefore, this review addresses this gap by discussing the factors that make the elderly more vulnerable to PM2.5-induced CVDs. Accordingly, we focused on physiological aging, increased susceptibility, cardiometabolic risk factors, CVDs, and biological mechanisms. This review concludes by examining potential interventions to reduce exposure and the adverse health effects of PM2.5 in the elderly population. The latter includes dietary modifications, medications, and exploration of the potential benefits of supplements. By comprehensively analyzing these factors, this review aims to provide a deeper understanding of the detrimental effects of PM2.5 on cardiovascular health in older adults. This knowledge can inform future research and guide strategies to protect vulnerable populations from the adverse effects of air pollution.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article